NCT04847882

Brief Summary

Our primary purpose is to compare the prevalence of sleep disorders in children aged 6 to 17 with cystic fibrosis versus controls with a Sleep disorder screening score, the SDSC. Our hypothesis is that patients aged 6 to 17 with cystic fibrosis have a higher prevalence of sleep disturbances than the general population of the same age group. Our secondary hypothesis is that these sleep disorders are mixed and that there are non-respiratory causes, sometimes modifiable by simple non-medical treatment and that's why our secondary purpose is to identify the responsible factors, in particular non-respiratory factors in the 2 groups and to compare them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

May 20, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 9, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2021

Completed
Last Updated

February 17, 2023

Status Verified

February 1, 2023

Enrollment Period

3 months

First QC Date

April 13, 2021

Last Update Submit

February 15, 2023

Conditions

Keywords

ChildrenCase control study

Outcome Measures

Primary Outcomes (1)

  • Questionnaire SDSC

    The specific measure for our first purpose is a validated questionnaire called SDSC for "Sleep Disturbance Scale for Children"

    15 minutes

Secondary Outcomes (1)

  • Questionnaire SDSC

    15 minutes

Study Arms (2)

Cystic fibrosis, children from 6 to 17.

This group is made up of children with cystic fibrosis followed at the Strasbourg pediatrics CRCM, aged from 6 to 17 years old, not hospitalized at the time of inclusion, without any other criterion prejudging the seriousness of the pathology.

Behavioral: Questionnaire

Control group, children from 6 to 17.

This group is the control group. It is made up of children consulting in pediatric surgical emergencies, aged 6 to 17 years. Surgical emergencies were chosen because it is a point of consultation, rather accidental, where sleep has often not been impacted in the previous months and where the frequency of chronic pathology is not higher than the general population. An other criteria is that these children are accompanied by at least one of their parents and that they can read and understand French well.

Behavioral: Questionnaire

Interventions

QuestionnaireBEHAVIORAL

Questionnaire submitted to the parents of children with cystic fibrosis aged 6 to 17 years and to controls in order to assess and compare the prevalence of sleep disorders and their main non-respiratory causes

Control group, children from 6 to 17.Cystic fibrosis, children from 6 to 17.

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children from 6 to 17 years with cystic fibrosis for the case group and children with an emergency surgical consultation for the control group

You may qualify if:

  • Cystic fibrosis followed at the pediatric (Centre de Ressources et de Compétences de la Mucoviscidose) in Strasbourg
  • Aged from 6 to 17 years old
  • Non hospitalized
  • Able to read and understand French language
  • Accompanied by at least one of his parents
  • Emergency surgical consultation
  • Aged from 6 to 17 years old
  • Non hospitalized
  • Able to read and understand French langage
  • Accompanied by at least one of his parents

You may not qualify if:

  • Children under 6 years old
  • Children over 17 years old
  • Children and parents who don't understand or can't read French language
  • Hospitalized children
  • Children unaccompanied by their parents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpitaux Universitaire de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

Cystic FibrosisSleep Wake Disorders

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 19, 2021

Study Start

May 20, 2021

Primary Completion

August 9, 2021

Study Completion

December 20, 2021

Last Updated

February 17, 2023

Record last verified: 2023-02

Locations